Metformin is the most commonly prescribed Type 2 diabetes drug, yet scientists still do not fully know how it works to control blood sugar levels. In …

The Food and Drug Administration (FDA) is investigating whether metformin sold in the U.S. contains a possible carcinogen. The U.S. Food and Drug …

Novo Nordisk announced that Ozempic (semaglutide injection) is now publicly listed in the province of Quebec under the Régie de L’assurance …

A drug commonly used to treat Type 2 diabetes abolishes the characteristic signs of nicotine withdrawal in rats and mice, according to new research. …

Innovent Biologics, Inc. announced that it has entered into a licensing agreement with Eli Lilly and Company for the development and potential …

AstraZeneca announced yesterday that the U.S. Food and Drug Administration (FDA) did not approve its diabetes treatment, Farxiga, for use as a …

Researchers at the University of Arizona have discovered that metformin, a drug commonly used to treat type 2 diabetes, might also be used to treat …

Astra Zeneca’s diabetes drug, Farxiga met primary endpoints in a large clinical study, showing a significant reduction in hospitalization rates …

The U.S. Food and Drug Administration is warning patients and doctors about a rare but serious infection that has been reported with a common class …

When tissue is damaged, one of the body’s first inflammatory immune-system responders are macrophages, cells which are commonly thought of as …